Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
G Robinet, P Thomas, J L Breton, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study
J B Auliac, C Chouaid, L Greillier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française
P Jacoulet, A Depierre, D Moro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2025
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study
M Wislez, C Mascaux, J Cadranel, et al.
Revue Des Maladies Respiratoires
|
March 19, 2013
[Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]
N Paleiron, M André, F Grassin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
J Mazières, F Barlesi, T Filleron, et al.
Targeted Oncology
|
August 29, 2015
Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study
J B Auliac, C Fournier, C Audigier Valette, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
August 28, 2016
[Prostate cancer of elderly patients: Place and role of geriatric assessment]
B Méry, A Vallard, S Espenel, et al.
ESMO Open
|
April 12, 2025
Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe study
S Quesada, A Puszkiel, A Jouinot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2015
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†
J-L Pujol, A Lavole, E Quoix, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
G Robinet, P Thomas, J L Breton, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 2, 2014
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study
J B Auliac, C Chouaid, L Greillier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 24, 1997
Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study. Groupe d'Oncologie de Langue Française
P Jacoulet, A Depierre, D Moro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 19, 2025
Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study
M Wislez, C Mascaux, J Cadranel, et al.
Revue Des Maladies Respiratoires
|
March 19, 2013
[Evaluation of preoperative non-invasive ventilation in thoracic surgery for lung cancer: the preOVNI study GFPC 12-01]
N Paleiron, M André, F Grassin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
J Mazières, F Barlesi, T Filleron, et al.
Targeted Oncology
|
August 29, 2015
Impact of Continuing First-Line EGFR Tyrosine Kinase Inhibitor Therapy Beyond RECIST Disease Progression in Patients with Advanced EGFR-Mutated Non-Small-Cell Lung Cancer (NSCLC): Retrospective GFPC 04-13 Study
J B Auliac, C Fournier, C Audigier Valette, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
August 28, 2016
[Prostate cancer of elderly patients: Place and role of geriatric assessment]
B Méry, A Vallard, S Espenel, et al.
ESMO Open
|
April 12, 2025
Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe study
S Quesada, A Puszkiel, A Jouinot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 18, 2015
Randomized phase II-III study of bevacizumab in combination with chemotherapy in previously untreated extensive small-cell lung cancer: results from the IFCT-0802 trial†
J-L Pujol, A Lavole, E Quoix, et al.
Page
of 9